ACCEL Lite: Top Takeaways From the 2020 HCM Guidelines
In this interview, Peter McCullough, MD, MPH, FACC; Steve Ommen, MD, FACC; and Poonam Velagapudi, MD, MS, discuss top takeaways from the 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy.
Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Congenital Heart Disease and Pediatric Cardiology, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Sports and Exercise Cardiology, Atherosclerotic Disease (CAD/PAD), Anticoagulation Management and Atrial Fibrillation, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Congenital Heart Disease, CHD and Pediatrics and Arrhythmias, CHD and Pediatrics and Imaging, CHD and Pediatrics and Interventions, CHD and Pediatrics and Quality Improvement, Acute Heart Failure, Interventions and Coronary Artery Disease, Interventions and Imaging, Interventions and Structural Heart Disease, Angiography, Echocardiography/Ultrasound, Magnetic Resonance Imaging, Nuclear Imaging, Sports and Exercise and Congenital Heart Disease and Pediatric Cardiology, Sports and Exercise and Imaging
Keywords: ACCELLite, Cardiomyopathy, Hypertrophic, Guidelines as Topic, Adrenergic beta-Antagonists, Anticoagulants, Arrhythmias, Cardiac, Atrial Fibrillation, Coronary Artery Disease, Coronary Angiography, Death, Sudden, Cardiac, Defibrillators, Implantable, Diagnostic Imaging, Echocardiography, Electrocardiography, Genetic Testing, Heart Failure, Magnetic Resonance Imaging, Myocardial Ischemia, Physical Examination, Pregnancy, Risk Factors, Secondary Prevention, Sports, Heart Defects, Congenital
< Back to Listings